|
EP2651439B1
(en)
|
2010-12-17 |
2018-09-19 |
Globeimmune, Inc. |
Compositions and methods for the treatment or prevention of human adenovirus-36 infection
|
|
US9238679B2
(en)
*
|
2011-02-11 |
2016-01-19 |
The Trustees Of The University Of Pennslyvania |
Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
|
|
US9403879B2
(en)
|
2011-02-11 |
2016-08-02 |
The Trustees Of The University Of Pennsylvania |
Nucleic acid molecule encoding hepatitis B virus core protein and vaccine comprising the same
|
|
PE20140844A1
(es)
|
2011-02-12 |
2014-07-14 |
Globeimmune Inc |
Terapeuticos a base de levadura para infeccion de la hepatitis b cronica
|
|
JP6068368B2
(ja)
|
2011-03-17 |
2017-01-25 |
グローブイミューン，インコーポレイテッド |
酵母−ブラキュリ免疫治療組成物
|
|
EP2720716B1
(en)
|
2011-06-14 |
2018-03-21 |
Globeimmune, Inc. |
Immunotherapeutic compositions for the treatment or prevention of hepatitis delta virus infection
|
|
CN109010809A
(zh)
|
2011-08-17 |
2018-12-18 |
全球免疫股份有限公司 |
酵母-muc1免疫治疗组合物及其用途
|
|
KR102103319B1
(ko)
|
2012-06-26 |
2020-04-22 |
바이오디식스, 인크. |
면역반응 발생 요법으로 치료하기 위해 암환자들의 선택, 및 선택해제를 위한 질량-스펙트럼법
|
|
US10413585B2
(en)
|
2012-11-12 |
2019-09-17 |
Ruprecht-Karls-Universität Heidelberg |
Lipopeptides for use in treating liver diseases and cardiovascular diseases
|
|
MX374829B
(es)
|
2013-03-19 |
2025-03-06 |
Globeimmune Inc |
Composición a base de levadura para usarse para tratar cordoma.
|
|
US9782473B2
(en)
|
2013-03-26 |
2017-10-10 |
Globeimmune, Inc. |
Compositions and methods for the treatment or prevention of human immunodeficiency virus infection
|
|
TWI654200B
(zh)
|
2013-08-30 |
2019-03-21 |
環球免疫公司 |
治療或預防結核病的組合物及方法
|
|
CA2948803A1
(en)
|
2014-04-11 |
2015-10-15 |
Globeimmune, Inc. |
Yeast-based immunotherapy and type i interferon sensitivity
|
|
WO2016085284A1
(ko)
*
|
2014-11-28 |
2016-06-02 |
(주)셀트리온 |
B형 간염 바이러스 표면 항원의 에피토프 및 이에 특이적으로 결합하는 b형 간염 바이러스 중화 결합 분자
|
|
US10695417B2
(en)
|
2015-01-09 |
2020-06-30 |
Etubics Corporation |
Human adenovirus serotype 5 vectors containing E1 and E2B deletions encoding the ebola virus glycoprotein
|
|
SG11201606876RA
(en)
|
2015-03-04 |
2016-10-28 |
Gilead Sciences Inc |
Toll like receptor modulator compounds
|
|
TWI748957B
(zh)
|
2015-08-03 |
2021-12-11 |
美商環球免疫公司 |
經修飾之酵母-短尾畸型（Ｂｒａｃｈｙｕｒｙ）免疫治療組合物
|
|
MA42684A
(fr)
|
2015-08-26 |
2018-07-04 |
Gilead Sciences Inc |
Modulateurs deutérés du récepteur toll
|
|
WO2017076988A1
(en)
*
|
2015-11-04 |
2017-05-11 |
Hookipa Biotech Ag |
Vaccines against hepatitis b virus
|
|
EP3402888B1
(en)
*
|
2016-01-12 |
2020-08-26 |
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Means and methods for treating hbv
|
|
BR102017010009A2
(pt)
|
2016-05-27 |
2017-12-12 |
Gilead Sciences, Inc. |
Compounds for the treatment of hepatitis b virus infection
|
|
EP3276006A1
(en)
*
|
2016-07-27 |
2018-01-31 |
Theravectys |
Lentiviral vectors for expression of hepatitis b virus (hbv) antigens
|
|
WO2018045150A1
(en)
|
2016-09-02 |
2018-03-08 |
Gilead Sciences, Inc. |
4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
|
|
SI3507276T1
(sl)
|
2016-09-02 |
2022-01-31 |
Gilead Sciences, Inc. |
Spojine modulatorja toličnih receptorjev
|
|
CN106421774B
(zh)
*
|
2016-09-08 |
2019-05-28 |
中国科学院生物物理研究所 |
PreS1用于制备乙肝疫苗以及治疗慢性乙型肝炎的用途
|
|
KR20230010826A
(ko)
|
2016-10-14 |
2023-01-19 |
프리시젼 바이오사이언시스 인코포레이티드 |
B형 간염 바이러스 게놈 내의 인식 서열에 대해 특이적인 조작된 메가뉴클레아제
|
|
TWI714820B
(zh)
|
2017-01-31 |
2021-01-01 |
美商基利科學股份有限公司 |
替諾福韋艾拉酚胺(tenofovir alafenamide)之晶型
|
|
UY37581A
(es)
|
2017-02-02 |
2018-08-31 |
Gilead Sciences Inc |
Compuestos para el tratamiento de la infección por virus de la hepatitis b
|
|
GB201705765D0
(en)
*
|
2017-04-10 |
2017-05-24 |
Univ Oxford Innovation Ltd |
HBV vaccine
|
|
BR102018007822A2
(pt)
|
2017-04-20 |
2018-11-06 |
Gilead Sciences, Inc. |
composto, métodos para inibir pd-1, pd-l1 e/ou interação de pd-1/pd-l1 e para tratamento de câncer, composição farmacêutica, e, kit para tratamento de ou prevenção de câncer ou uma doença ou condição
|
|
CN110612118B
(zh)
*
|
2017-06-05 |
2024-02-13 |
比科尔公司 |
用于引起针对hbv的免疫应答的病毒样粒子
|
|
KR102891807B1
(ko)
|
2017-08-22 |
2025-12-01 |
길리애드 사이언시즈, 인코포레이티드 |
치료 헤테로시클릭 화합물
|
|
CA3085492A1
(en)
*
|
2017-12-19 |
2019-06-27 |
Janssen Sciences Ireland Unlimited Company |
Methods and apparatus for the delivery of hepatitis b virus (hbv) vaccines
|
|
MA51311A
(fr)
*
|
2017-12-19 |
2020-10-28 |
Janssen Sciences Ireland Unlimited Co |
Vaccins contre le virus de l'hépatite b (vhb) et utilisations associées
|
|
EA202091517A1
(ru)
|
2017-12-19 |
2020-11-03 |
Янссен Сайенсиз Айрлэнд Анлимитед Компани |
Способы и устройство для доставки вакцин против вируса гепатита b (hbv)
|
|
EA202091516A1
(ru)
|
2017-12-19 |
2020-11-03 |
Янссен Сайенсиз Айрлэнд Анлимитед Компани |
Способы и композиции для индукции иммунного ответа против вируса гепатита b (hbv)
|
|
EA202091513A1
(ru)
|
2017-12-19 |
2020-09-09 |
Янссен Сайенсиз Айрлэнд Анлимитед Компани |
Вакцины против вируса гепатита b (hbv) и их применение
|
|
US11203610B2
(en)
|
2017-12-20 |
2021-12-21 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2′3′ cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
|
JP7037667B2
(ja)
|
2017-12-20 |
2022-03-16 |
インスティチュート オブ オーガニック ケミストリー アンド バイオケミストリー エーエスシーアール，ヴイ．ヴイ．アイ． |
Ｓｔｉｎｇアダプタータンパク質を活性化するホスホン酸結合を有する３’３’環状ジヌクレオチド
|
|
WO2019160882A1
(en)
|
2018-02-13 |
2019-08-22 |
Gilead Sciences, Inc. |
Pd-1/pd-l1 inhibitors
|
|
JP7050165B2
(ja)
|
2018-02-26 |
2022-04-07 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｈｂｖ複製阻害剤としての置換ピロリジン化合物
|
|
SG11202008539YA
(en)
|
2018-03-06 |
2020-10-29 |
Precigen Inc |
Human papillomavirus vaccines and uses of the same
|
|
IL277128B2
(en)
*
|
2018-03-06 |
2025-11-01 |
Precigen Inc |
Hepatitis b vaccines and uses of the same
|
|
WO2019195181A1
(en)
|
2018-04-05 |
2019-10-10 |
Gilead Sciences, Inc. |
Antibodies and fragments thereof that bind hepatitis b virus protein x
|
|
TWI833744B
(zh)
|
2018-04-06 |
2024-03-01 |
捷克科學院有機化學與生物化學研究所 |
3'3'-環二核苷酸
|
|
TW202005654A
(zh)
|
2018-04-06 |
2020-02-01 |
捷克科學院有機化學與生物化學研究所 |
２，２，─環二核苷酸
|
|
TWI818007B
(zh)
|
2018-04-06 |
2023-10-11 |
捷克科學院有機化學與生物化學研究所 |
2'3'-環二核苷酸
|
|
US11142750B2
(en)
|
2018-04-12 |
2021-10-12 |
Precision Biosciences, Inc. |
Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
|
|
KR102591947B1
(ko)
|
2018-04-19 |
2023-10-25 |
길리애드 사이언시즈, 인코포레이티드 |
Pd-1/pd-l1 억제제
|
|
WO2019211799A1
(en)
|
2018-05-03 |
2019-11-07 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide
|
|
CN119818663A
(zh)
|
2018-05-15 |
2025-04-15 |
全球免疫公司 |
用于诱导细胞免疫应答的重组酵母裂解物
|
|
AU2019297428C1
(en)
|
2018-07-06 |
2023-03-23 |
Gilead Sciences, Inc. |
Therapeutic heterocyclic compounds
|
|
CN112384505B
(zh)
|
2018-07-06 |
2025-05-27 |
吉利德科学公司 |
治疗性的杂环化合物
|
|
PE20210642A1
(es)
|
2018-07-13 |
2021-03-23 |
Gilead Sciences Inc |
Inhibidores de pd-1/pd-l1
|
|
WO2020028097A1
(en)
|
2018-08-01 |
2020-02-06 |
Gilead Sciences, Inc. |
Solid forms of (r)-11-(methoxymethyl)-12-(3-methoxypropoxy)-3,3-dimethyl-8-0x0-2,3,8,13b-tetrahydro-1h-pyrido[2,1-a]pyrrolo[1,2-c] phthalazine-7-c arboxylic acid
|
|
US11236085B2
(en)
|
2018-10-24 |
2022-02-01 |
Gilead Sciences, Inc. |
PD-1/PD-L1 inhibitors
|
|
EP4371987B9
(en)
|
2018-10-31 |
2025-11-26 |
Gilead Sciences, Inc. |
Substituted 6-azabenzimidazole compounds as hpk1 inhibitors
|
|
EP3873608A1
(en)
|
2018-10-31 |
2021-09-08 |
Gilead Sciences, Inc. |
Substituted 6-azabenzimidazole compounds having hpk1 inhibitory activity
|
|
CN113574063B
(zh)
|
2019-03-07 |
2025-03-18 |
捷克共和国有机化学与生物化学研究所 |
3’3’-环二核苷酸及其前药
|
|
WO2020178769A1
(en)
|
2019-03-07 |
2020-09-10 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3'-cyclic dinucleotides and prodrugs thereof
|
|
WO2020178768A1
(en)
|
2019-03-07 |
2020-09-10 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator
|
|
TW202210480A
(zh)
|
2019-04-17 |
2022-03-16 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
TWI751517B
(zh)
|
2019-04-17 |
2022-01-01 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
US11453681B2
(en)
|
2019-05-23 |
2022-09-27 |
Gilead Sciences, Inc. |
Substituted eneoxindoles and uses thereof
|
|
WO2020255038A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and pyridopyrimidine derivatives
|
|
WO2020254876A1
(en)
*
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Virus-like particle delivery of hepatitis b virus (hbv) vaccines
|
|
CN114245807B
(zh)
|
2019-06-25 |
2025-05-02 |
吉利德科学公司 |
Flt3l-fc融合蛋白和使用方法
|
|
WO2021011891A1
(en)
|
2019-07-18 |
2021-01-21 |
Gilead Sciences, Inc. |
Long-acting formulations of tenofovir alafenamide
|
|
US20220296619A1
(en)
|
2019-08-19 |
2022-09-22 |
Gilead Sciences, Inc. |
Pharmaceutical formulations of tenofovir alafenamide
|
|
BR112022003474A2
(pt)
|
2019-08-29 |
2022-05-24 |
Triad Nat Security Llc |
Vacinas do vírus da hepatite b
|
|
WO2021060450A1
(ja)
*
|
2019-09-27 |
2021-04-01 |
富士レビオ株式会社 |
Ｂ型肝炎ウイルスコア関連抗原のイムノアッセイ及びそのためのキット
|
|
HRP20241379T1
(hr)
|
2019-09-30 |
2024-12-20 |
Gilead Sciences, Inc. |
Cjepiva za hbv i postupci za liječenje hbv
|
|
US12410418B2
(en)
|
2019-12-06 |
2025-09-09 |
Precision Biosciences, Inc. |
Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
|
|
CN115335076B
(zh)
*
|
2020-01-09 |
2025-10-28 |
病毒治疗有限责任公司 |
编码与疱疹病毒糖蛋白d融合的乙型肝炎病毒抗原的腺病毒载体及其使用方法
|
|
US11857620B2
(en)
|
2020-03-11 |
2024-01-02 |
Immunitybio, Inc. |
Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirus
|
|
US20210284716A1
(en)
|
2020-03-11 |
2021-09-16 |
Immunitybio, Inc. |
ACE2-Fc Trap
|
|
US12285480B2
(en)
|
2020-03-11 |
2025-04-29 |
Nantcell, Inc. |
Method of inducing immunity against SARS-CoV-2 using spike and nucleocapsid-ETSD immunogens delivered by RNA and replication-defective adenoviruses
|
|
KR102987126B1
(ko)
|
2020-03-20 |
2026-07-07 |
길리애드 사이언시즈, 인코포레이티드 |
4'-c-치환된-2-할로-2'-데옥시아데노신 뉴클레오시드의 프로드러그 및 이의 제조 및 사용 방법
|
|
EP4171594A4
(en)
*
|
2020-06-29 |
2024-08-07 |
The Trustees Of Columbia University In The City Of New York |
YEAST-BASED VACCINES
|
|
LT4192474T
(lt)
|
2020-08-07 |
2025-11-25 |
|
Fosfonamidų nukleotidų analogų provaistai ir jų farmacinis panaudojimas
|
|
TWI815194B
(zh)
|
2020-10-22 |
2023-09-11 |
美商基利科學股份有限公司 |
介白素2-Fc融合蛋白及使用方法
|
|
US20240269142A1
(en)
|
2021-05-13 |
2024-08-15 |
Gilead Sciences, Inc. |
COMBINATION OF A TLR8 MODULATING COMPOUND AND ANTI-HBV siRNA THERAPEUTICS
|
|
CN117355531A
(zh)
|
2021-06-23 |
2024-01-05 |
吉利德科学公司 |
二酰基甘油激酶调节化合物
|
|
EP4359413A1
(en)
|
2021-06-23 |
2024-05-01 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
MX2023014762A
(es)
|
2021-06-23 |
2024-01-15 |
Gilead Sciences Inc |
Compuestos moduladores de diacilglicerol quinasa.
|
|
JP7651018B2
(ja)
|
2021-06-23 |
2025-03-25 |
ギリアード サイエンシーズ， インコーポレイテッド |
ジアシルグリセロールキナーゼ調節化合物
|
|
WO2023085956A1
(en)
*
|
2021-11-09 |
2023-05-19 |
Avalia Immunotherapies Limited |
Novel therapeutic vaccines
|
|
WO2024220982A1
(en)
*
|
2023-04-21 |
2024-10-24 |
The Wistar Institute Of Anatomy And Biology |
Compositions comprising aptamers and methods of modulating the immune response using the same
|
|
TW202608468A
(zh)
|
2024-05-13 |
2026-03-01 |
美商基利科學股份有限公司 |
組合療法
|
|
US20250345390A1
(en)
|
2024-05-13 |
2025-11-13 |
Gilead Sciences, Inc. |
Combination therapies
|
|
WO2025240246A1
(en)
|
2024-05-13 |
2025-11-20 |
Gilead Sciences, Inc. |
Combination therapies with ribavirin
|
|
WO2025240242A1
(en)
|
2024-05-13 |
2025-11-20 |
Gilead Sciences, Inc. |
Combination therapies with ribavirin
|
|
WO2026093412A2
(en)
*
|
2024-10-29 |
2026-05-07 |
Nec Oncoimmunity As |
Hbv vaccine
|